TMEM39A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.498980E-01
Normal-vs-Stage2
2.086000E-01
Normal-vs-Stage3
7.358600E-01
Normal-vs-Stage4
5.547600E-02
Stage1-vs-Stage2
9.752400E-01
Stage1-vs-Stage3
1.909430E-01
Stage1-vs-Stage4
8.858200E-02
Stage2-vs-Stage3
2.425600E-01
Stage2-vs-Stage4
2.990000E-02
Stage3-vs-Stage4
3.978300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.424800E-01
Normal-vs-AfricanAmerican
1.344000E-01
Normal-vs-Asian
5.301400E-01
Caucasian-vs-AfricanAmerican
2.042000E-01
Caucasian-vs-Asian
2.643800E-01
AfricanAmerican-vs-Asian
9.055700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.606000E-01
Normal-vs-Female
2.086400E-01
Male-vs-Female
8.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.712180E-01
Normal-vs-Age(41-60Yrs)
9.916000E-02
Normal-vs-Age(61-80Yrs)
3.273600E-01
Normal-vs-Age(81-100Yrs)
4.496600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.440400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.571800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.905000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.127520E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.843800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.076800E-01
Normal-vs-Daily Drinker
4.734800E-01
Normal-vs-Weekly Drinker
3.730200E-01
Normal-vs-Occasional Drinker
2.841000E-01
Normal-vs-Social Drinker
1.608200E-01
Non Drinker-vs-Daily Drinker
8.445400E-01
Non Drinker-vs-Weekly Drinker
7.729000E-01
Non Drinker-vs-Occasional Drinker
1.768370E-01
Non Drinker-vs-Social Drinker
3.752400E-02
Daily Drinker-vs-Weekly Drinker
6.688200E-01
Daily Drinker-vs-Occasional Drinker
1.528210E-01
Daily Drinker-vs-Social Drinker
4.214200E-02
Weekly Drinker-vs-Occasional Drinker
3.274200E-01
Weekly Drinker-vs-Social Drinker
1.520240E-01
Occasional Drinker-vs-Social Drinker
7.310400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.541400E-01
Normal-vs-Grade 2
4.537600E-02
Normal-vs-Grade 3
5.794000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.185580E-01
Grade 1-vs-Grade 3
4.055900E-02
Grade 1-vs-Grade 4
3.541400E-01
Grade 2-vs-Grade 3
3.819800E-01
Grade 2-vs-Grade 4
4.537600E-02
Grade 3-vs-Grade 4
5.794000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.845600E-01
Normal-vs-NonDiabetic
2.895200E-01
Diabetic-vs-NonDiabetic
6.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.243200E-01
Normal-vs-NoPancreatitis
2.889200E-01
Pancreatitis-vs-NoPancreatitis
9.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.380800E-01
Normal-vs-N1
1.907000E-01
N0-vs-N1
3.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.851640E-01
Normal-vs-TP53-NonMutant
3.251400E-01
TP53-Mutant-vs-TP53-NonMutant
1.463190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
